Northern Institute for Cancer Research

Staff Profile

Dr Emma Clark

Research Associate

Background

Personal Summary

Building on a strong prostate cancer research background I have moved my research interest focus away from basic, early discovery research to build urological clinical research expertise. Where basic science has shown the potential to make a real difference I aim to work this to the next stage in order to move this to clinical practice as quickly as possible. I work with a portfolio of clinical trial studies where I have taken management of the translational lead and facilitate gaining funding for these types of studies.

Qualifications

PGCert 2015 Clinical Research, Newcastle University, UK

PhD 2006 Molecular Cancer Biology, Newcastle University, UK

BSc 1999 (Hons) Biochemistry, University of Sussex, UK

Previous Positions

2006-2014 Research Associate - Urological Cancer, Northern Institute for Cancer Research, Newcastle University, UK

2002- 2005 BBSRC (GSK Case) PhD Student - Institute for Cell & Molecular Biosciences, Newcastle Univeristy, UK

2001-2002 Research Assistant - Dept. of Fetal Medicine, Birmingham Womens Hospital, UK

1999-2001 Graduate Pharmaceutical Scientific Researcher - Roche, Welwyn Garden City, UK

1997-1998 Industrial Studentship Placement - Home Office Forensic Science Service, Birmingham, UK




Research

Research Interests

Biomarker Discovery - prognostic and predictive in terms of treatment/disease outcomes

Androgen Receptor (AR) transcriptional control - co-regulatory and post-translational mechanisms
Molecular biology of hormone escape in Prostate Cancer (PCa)

p68 DEAD Box RNA Helicase (DdX5) cellular function

Funding 

PCUK PhD funded post (Characterising novel phosphatse enzymes important in regulating androgen receptor function in the progression of castrate resistant prostate cancer - £100.3K) awarded to Dr. E. L. Clark and Prof. C. N. Robson (Sept 2013-Sept 2016) 

JGWP funded technical post (Assessing the role of RNA helicase p68 (Ddx5) in the deregulation of microRNAs and progression of Prostate Cancer - £52K) awarded to Dr. E. L. Clark and Prof. C. N. Robson (May 2012-May 2013)

Prostate Action funded grant (Assessing RNA helicase p68 (Ddx5) as a biomarker in the deregulation of microRNAs in Prostate Cancer - £99,987) awarded to Dr. E. L. Clark and Prof. C. N. Robson (Jan 2012-Oct 2013)

Prostate Cancer Research Foundation (PCRF) funded grant (Pharmacological perturbation of p68 - an important androgen receptor transcriptional co-regulator in prostate cancer - £99,941) awarded to Dr. E. L. Clark and Prof. C. N. Robson (Jan 2008- Dec 2011)

Industrial Relevance

1999 - 2001 Graduate Pharmaceutical Scientific Researcher, Roche, Welwyn Garden City, UK

 

Teaching

Postgraduate Teaching

Supervise MRes and PhD project students in the lab

Publications